Literature DB >> 27165199

Determination of a Change Point in the Age at Diagnosis of Breast Cancer Using a Survival Model.

Mahbubeh Abdollahi1, Ebrahim Hajizadeh, Ahmad Reza Baghestani, Shahpar Haghighat.   

Abstract

Breast cancer, the second cause of cancer-related death after lung cancer and the most common cancer in women after skin cancer, is curable if detected in early stages of clinical presentation. Knowledge as to any age cut-off points which might have significance for prognostic groups is important in screening and treatment planning. Therefore, determining a change-point could improve resource allocation. This study aimed to determine if a change point for survival might exist in the age of breast cancer diagnosis. This study included 568 cases of breast cancer that were registered in Breast Cancer Research Center, Tehran, Iran, during the period 1986-2006 and were followed up to 2012. In the presence of curable cases of breast cancer, a change point in the age of breast cancer diagnosis was estimated using a mixture survival cure model. The data were analyzed using SPSS (versions 20) and R (version 2.15.0) software. The results revealed that a change point in the age of breast cancer diagnosis was at 50 years age. Based on our estimation, 35% of the patients diagnosed with breast cancer at age less than or equal to 50 years of age were cured while the figure was 57% for those diagnosed after 50 years of age. Those in the older age group had better survival compared to their younger counterparts during 12 years of follow up. Our results suggest that it is better to estimate change points in age for cancers which are curable in early stages using survival cure models, and that the cure rate would increase with timely screening for breast cancer.

Entities:  

Mesh:

Year:  2016        PMID: 27165199     DOI: 10.7314/apjcp.2016.17.s3.5

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes.

Authors:  Afsaneh Fendereski; Ebrahim Hajizadeh; Shahpar Haghighat; Aliakbar Rasekhi
Journal:  BMC Womens Health       Date:  2022-07-04       Impact factor: 2.742

2.  A little help from my friends: social support in palliative rehabilitation.

Authors:  N A Rutkowski; S Lebel; K Richardson; B Mutsaers; M Chasen; A Feldstain
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

3.  High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy.

Authors:  Chuanhui Xu; Jinhui Yu; Feifei Wu; Xuemei Li; Dongmin Hu; Guiming Chen; Gang Wu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Excessive Pretreatment Weight Loss Is a Risk Factor for the Survival Outcome of Esophageal Carcinoma Patients Undergoing Radical Surgery and Postoperative Adjuvant Chemotherapy.

Authors:  Xiao-Li Yu; Jin Yang; Ting Chen; Yi-Min Liu; Wei-Ping Xue; Ming-Hui Wang; Shou-Min Bai
Journal:  Can J Gastroenterol Hepatol       Date:  2018-01-28

Review 5.  Age at Diagnosis of Breast Cancer in Iran: A Systematic Review and Meta-Analysis.

Authors:  Mahasti Alizadeh; Morteza Ghojazadeh; Reza Piri; Mohammad Mirza-Aghazadeh-Attari; Sahar Mohammadi; Mohammad Naghavi-Behzad
Journal:  Iran J Public Health       Date:  2021-08       Impact factor: 1.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.